SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK)
ANNUAL REPORT & ACCOUNTS 31ST MARCH 2023
Registered Charity Number 1181463
EDMUND CARR LLP
Chartered Accountants 146 New London Road Chelmsford Essex CM2 0AW
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK)
YEAR ENDED 31 MARCH 2023
----- Start of picture text -----
CONTENTS
Trustees (The Executive Committee) 1
Report of the Trustees 2
Independent examiner's report 7
Statement of Financial Activities (incorporating the income 8
and expenditure account)
Balance Sheet 9
Notes to the financial statements 10
----- End of picture text -----
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) REFERENCE AND ADMINISTRATIVE DETAILS
YEAR ENDED 31 MARCH 2023
----- Start of picture text -----
Registered Charity Name Scoliosis Support and Research (with effect from January 2024)
formerly Scoliosis Association UK (SAUK)
Charity Number 1181463
Registered Office Ground Floor
329 Latimer Road
London
W10 6RA
Trustees Mr I Nelson (Chair) (appointed 1/1/23, Co-chair to 31/12/23)
Dr. S Clark (resigned 31/12/23, Chair to 31/12/22, Co-chair to 31/12/23)
Dr R Levene (resigned 31/12/23)
Mr C Nnadi
Mrs C Richards (resigned 1/1/23)
Ms S Kraft (resigned 31/12/23)
Dr N Jones
Mr T Tsirikos
Dr S Spencer (resigned 1/9/22)
Mr P Millner (appointed 1/1/23)
Mr J Leong (appointed 1/1/23)
Dr M Noordeen (appointed 1/1/23)
Ms R Weil (appointed 1/1/23)
Mr J Zorab (appointed 1/1/23)
Chief Executive Lesley McGinty
Accountants Edmund Carr LLP
Chartered Accountants
146 New London Road
Chelmsford
Essex
CM2 0AW
Bankers CAF Bank
25 Kings Hill Avenue
Kings Hill
West Malling
Kent
ME19 4JQ
----- End of picture text -----
1
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) TRUSTEES' ANNUAL REPORT
YEAR ENDED 31 MARCH 2023
The Trustees have pleasure in presenting their report and the unaudited financial statements of the charity for the year ended 31 March 2023.
Aims
Scoliosis Support and Research UK (SSR) is the only UK-wide patient support organisation for people with scoliosis and their families. Our Vision is to promote the physical and mental wellbeing of people with scoliosis and their families. Our Mission is to provide advice, support, and information to people affected by scoliosis and their families, and to raise awareness of scoliosis and educate health professionals and the general public about the disorder.
Many people have never heard of scoliosis and do not have an understanding of the effect it can have on peoples’ lives. A diagnosis of scoliosis can leave people feeling isolated and unsure where to turn. At SSR, our aim is to be there for people with scoliosis and those close to them so that we can help them to access the care they need, both physically and mentally, reduce feelings of isolation, and to address poor body image, worry, fear, and lack of information.
Supporting our members and raising awareness of scoliosis
We give people with scoliosis a voice. We represent their views and concerns and encourage support for better resources and understanding of the condition. We run a membership network that allows people with scoliosis to contact each other and offers the support of a SSR Regional Representative. We provide health information publications in accordance with the NHS Information Standard as was, which means our information is up-to-date, accurate, and has been checked by specialists. We run a Helpline through which people can call or email the SSR team for advice, support, or just someone to talk to. We produce a twiceyearly magazine called Backbone, which is full of practical advice, support, and information. We hold patient meetings in specialist centers and online, at which specialists provide advice about scoliosis and people have the chance to ask questions. We instigated an annual International Scoliosis Day (ISAD) in 2013 to help raise awareness of scoliosis. It is now a major event with activities taking place all over the country. We keep an up-to-date list of scoliosis specialists, allowing people with scoliosis to find out where to go for the best available treatment. Online we have a strong social media presence on Facebook, Twitter, and Instagram through which people affected by scoliosis can connect. See www.ssr.org.uk. Three large legacies have enabled us to set up the Hill Pedder and Minns fund (named after the donors) to help our members with travel expenses and equipment. The Fund started with £39,768 and we have paid out £3,052 in 2022/23. When one of our founding trustees died some time ago, we formed the Isobel Gray Award for services to SSR in her memory. We also have a Roll of Honour for special bravery during treatment and it is awarded to many young people each year, with special mention in Backbone.
2
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) TRUSTEES' ANNUAL REPORT (continued)
YEAR ENDED 31 MARCH 2023
SSR is also supporting research by collaborating with researchers and making our members aware of the research and inviting them to participate. Please see below for further information about our merger with the British Scoliosis Research Foundation. Post merger, we have continued with the Charles Manning Award, which was a BSRF award arising from a legacy by Mr. Charles Manning, FRCS, to help early career researchers attend conferences to present their work. We awarded a total of £3,090 during this financial year.
The online Q&A sessions with spinal consultants have proved very popular with our members and are well attended. We will be continuing them for the foreseeable future but aim to restart our regional meetings, hosted by scoliosis centres, in the coming months. International Scoliosis Awareness Day (ISAD) was very successful this year, focussing on social media, which really encouraged people to post their own stories. We were featured on BBC London as part of a series on “invisible disabilities”. This story was broadcast on the 3rd of July 2022. It was on BBC One London four times that day, was on the front page of BBC news, and was featured on YouTube and all BBC London social media pages.
Regional Representatives
SSR has a nationwide network of over 40 volunteer Regional Representatives, which enables us to put our members in touch with those in their area so that they have somebody local to talk to. SSR Regional Representatives support our members locally and help to raise awareness of scoliosis. Some have regional Facebook groups and organise regular get-togethers.
Publications
SSR had Information Standard accreditation, which has now been discontinued by NHS England. It was a certification scheme for all organisations producing evidence-based health and social care information for the public. SSR has continued to apply this standard to all its relevant publications so that the public and patients can depend on reliable sources of good quality and evidence-based information. SSR health information is almost always written by specialists and is peer reviewed as part of our rigorous checks of information that we provide for our members. www.ssr.org.uk/scoliosisinformation
3
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) TRUSTEES' ANNUAL REPORT (continued)
YEAR ENDED 31 MARCH 2023
Structure, governance, and management
SSR was incorporated on January 7th, 2019, as Scoliosis Association UK (SAUK), a company limited by guarantee. The company is entered in the Central Register of Charities by the Charity Commissioners for England and Wales with registration number 1181463. SSR is governed by a board of Trustees, consisting of a combination of spinal surgeons, general practitioners, scientists, and lay members. The office staff is composed of a Chief Executive, supported by a Communications Officer and a Membership and Accounts Officer.
The Board of Trustees meets four times a year and the Chief Executive reports formally to the Board at these meetings. New Trustees are generally selected from contacts with knowledge of scoliosis and related issues. The Trustees confirm that they have had due regard to guidance published by the Charity Commission on public benefit. SSR’s aims are wholly directed at delivering public benefit.
Merger with the British Scoliosis Research Foundation
SSR has a long history of collaboration with its affiliated charity, the British Scoliosis Research Foundation (BSRF), which supports and funds research into scoliosis and other spinal conditions. In the previous financial year, both charities were fortunate to have received substantial legacies, putting both in a very stable financial situation. These factors led the Boards of both charities to agree to a formal merger of the two, who already worked closely together. There are many benefits to this merger, not least the ability to bring together support and research to help to provide the best possible care and support for anyone affected by scoliosis or other spinal conditions. At the heart of both charities is the well-being of every one of those people. A united charity provides a single point of contact for all things scoliosis and a stronger voice. The merged charity will benefit all patients because there will be greater opportunity for involvement in research, which will help to inform future treatments and clinical work and provide a clear pathway to support and provision of information and the ability to advocate for all patients in a much more coherent way. Costs are reduced and simplified and wider objectives mean that fundraising can be much more effective, with a greater range of possible funders. Post-pandemic, raising significant funds is more important than ever for all charities, and a blended, costeffective approach will have more impact than separate approaches. Potential donors are often more willing to support one charity and one cause wholly, instead of splitting their donations between two different organisations.
The merger was officially complete as of 1st January 2023, with members of the BSRF Council being co-opted onto a joint board at the December 2022 Board meeting. The new Board agreed Dr Stephanie Clark, PhD, and Mr Ian Nelson, FRCS, as co-Chairs of the new organisation. The Board also agreed that the merged charity would continue to operate under the SAUK name for the first year, after which the new name (SSR) and associated rebrand would be launched in January 2024.
The plan post-merger is to have several panels with specific responsibilities related to the functioning of the former organisations.
4
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) TRUSTEES' ANNUAL REPORT (continued) YEAR ENDED 31 MARCH 2023
Trustees
SSR Trustees during 2022/23 were:
Dr Stephanie Clark, PhD, (Chair and co-Chair); Mr Thanos Tsirikos, FRCS; Dr Nicholas Jones MB; Mrs Carol Richards, Ms Susannah Kraft; Mr Colin Nnadi, FRCS; Dr Stuart Spencer and Dr Rachel Levene, MB. Dr Stuart Spencer resigned in 2022 and Mrs Carol Richards stood down at the point of merger. Both had made invaluable contributions to SSR. BSRF Council members who were co-opted onto the Board in advance of the merger were: Mr Ian Nelson, FRCS, (co-Chair); Mr James Zorab; Prof Hilali Noordeen, FRCS; Ms Rebecca Weil, PhD, Mr Julian Leong, FRCS; Mr Peter Millner, FRCS. Mr Christopher Weatherley, FRCS, and Mr Andrew Clarke, FRCS, stood down when the merger took place. Both had been long serving Board members. Mr Weatherley had been a member of the Grants Committee for many years and provided valuable insights in his assessments of applications. Mr Clarke had organised many successful international Zorab Symposia.
HRH Princess Eugenie is SSR’s Royal Patron, and the other Patrons are David Rintoul, Actor, and Pippa Britton, Paralympic archer.
The staff team during 2022-23 consisted of Mrs Lesley McGinty, who has been in post as Chief Executive since April 2021, Natalie Cooper, Communications Officer since 2019, and Denise Aulsberry as Membership and Finance Officer for 26 years. All employees are based at SSR's premises at 325 Latimer Road, West London, and the office was moved to 329 Latimer Road in June 2023.
Finance
Two substantial legacies and the merger meant that the organisation ended 2022/23 with an exceptionally high income of over £1million. Unrestricted income, made up of donations, legacies, and fundraised income including Gift Aid was £513,153 compared with £141,276 in the previous year, but legacies rose from £11,000 to £373,263. Notably, Community Fundraising recovered from the effects of Covid and increased from £63,437 to £73,670. Our membership subscriptions stayed much the same as in 2021-22. SSR spent £189,129 in the current year compared with £197,736 in the previous year because we worked to make our systems and office services more efficient as well as streamlining our financial processes. SSR is developing new projects and ways to support people with scoliosis, with the benefit of the increased funds. As a precursor to the merger, the internationally renowned Zorab Symposium, which has been historically organised by BSRF, was organised by SSR and this also generated a small profit. SSR holds almost all its assets as cash deposits and total funds amounted to £1,217,690 at the year end, of which £671,990 is unrestricted. SSR’s reserve policy is to maintain a minimum of £100,000 of unrestricted funds. This policy is being reviewed post-merger alongside considering investment options for our surplus funds.
5
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) TRUSTEES' ANNUAL REPORT (continued)
YEAR ENDED 31 MARCH 2023
The financial statements have been prepared in accordance with the accounting policies set out in notes to the accounts and comply with the charity’s governing document, the Charities Act 2011 and Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland published on 16 July 2014. This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies’ exemption.
Approved by the Trustees on 25 January 2024 and signed on their behalf by:
........................................
Ian Nelson Chair of the Trustees
6
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES
YEAR ENDED 31 MARCH 2023
I report to the charity trustees on my examination of the accounts of the charity for the year ended 31 March 2023 which are set out on pages 8 to 17.
Responsibilities and basis of report
As the charity’s trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).
An independent examination has taken place instead of an audit. The charity's gross income in the year exceeded the audit threshold due to a transfer of assets from the British Scoliosis Research Foundation. Dispensation was granted by the Charity Commission on 5 October 2023 from the requirement to have an audit under Regulation 34(3)(a) of the Charities (accounts and Reports) Regulations 2008.
I report in respect of my examination of the charity’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.
Independent examiner's statement
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
-
accounting records were not kept in respect of the charity as required by section 130 of the Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
................................... Colin Barker FCA
Edmund Carr LLP 146 New London Road Chelmsford CM2 0AW
25 January 2024
7
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) STATEMENT OF FINANCIAL ACTIVITIES YEAR ENDED 31 MARCH 2023
| Note Income from: Donations and legacies 2 Other trading activities 3 Investments 4 Charitable activities 5 Transfer of assets 9 Other Total Income Expenditure on: Raising funds Charitable activities 6 Total Expenditure Net income/(expenditure) Transfers between funds Net Movement in Funds Reconciliation of Funds Total funds brought forward Total Funds Carried Forward |
Unrestricted Funds 2023 £ 513,153 3,881 6,808 32,876 462,308 60 1,019,086 6,186 179,853 186,039 833,047 - 833,047 337,791 £1,170,838 |
Restricted Funds 2023 £ - - - - 30,854 - 30,854 - 3,090 3,090 27,764 - 27,764 19,088 £46,852 |
Total Funds 2023 £ 513,153 3,881 6,808 32,876 493,162 60 1,049,940 6,186 182,943 189,129 860,811 - 860,811 356,879 £1,217,690 |
Total Funds 2022 £ 141,276 10,939 52 15,446 - 698 168,411 12,068 185,668 197,736 (29,325) - ( 29,325) 386,204 £356,879 |
|---|---|---|---|---|
All of the above amounts relate to continuing activities.
The notes on pages 11 to 17 form part of these financial statements.
8
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) BALANCE SHEET
AS AT 31 MARCH 2023
| Note Fixed Assets Tangible fixed assets 11 Current Assets Debtors 12 Cash at bank and in hand Creditors: Amounts falling due within one year 13 Net Current Assets Net Assets The funds of the charity: Unrestricted Funds 15 Designated Funds Total Unrestricted Funds Restricted Funds 16 Total Charity Funds |
£ £ 1,332 5,537 1,362,643 1,368,180 (151,822) 1,216,358 1,217,690 671,990 498,848 1,170,838 46,852 1,217,690 2023 |
£ £ - 10,399 353,118 363,517 (6,638) 356,879 356,879 298,049 39,742 337,791 19,088 356,879 2022 |
|---|---|---|
These financial statements were approved by the Trustees on 25 January 2024 and are signed on their behalf by:
…................................................
IAN NELSON (CHAIR OF THE TRUSTEES)
The notes on pages 11 to 17 form part of these financial statements.
9
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) CASHFLOW STATEMENT YEAR ENDED 31 MARCH 2023
| Note Cash flows from operating activities: Net movement in funds Adjustments for: Depreciation charges 11 Investment income 4 Decrease / (increase) in debtors 12 Increase / (decrease) in creditors 13 Cash provided by / (used in) operating activities Cash flows from investing activities: Investment income 4 Purchase of fixed assets 11 Cash provided by investing activities Increase / (decrease) in cash and cash equivalents in the year Cash and cash equivalents at start of year Cash and cash equivalents at end of year |
2023 860,811 444 (6,808) 4,862 145,184 1,004,493 6,808 (1,776) 5,032 1,009,525 353,118 1,362,643 |
2022 (29,325) - (52) 1,409 (4,492) (32,460) 52 - 52 (32,408) 385,526 353,118 |
|---|---|---|
The notes on pages 11 to 17 form part of these financial statements.
10
YEAR ENDED 31 MARCH 2023
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) NOTES TO THE FINANCIAL STATEMENTS
1) ACCOUNTING POLICIES
General informationand basisi of preparation
Scoliosis Association UK is a Charitable Incorporated Organisation, registered in England and Wales (charity no: 1181463).
The charity constitutes a public benefit entity as defined by FRS102.
The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial reporting Standard applicable in the UK and Republic of Ireland (FRS102) issued in October 2019, the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102), the Charities Act 2011 and UK Generally Accepted Accounting Practice.
The financial statements have been prepared to give a ‘true and fair’ view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a ‘true and fair view’. This departure has involved following the Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019 rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn.
The financial statements are prepared on a going concern basis under the historical cost convention modified to include certain items at fair value. The financial statements are presented in sterling which is the functional currency of the charity and rounded to the nearest £1.
The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.
Income recognition
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of the income can be measured reliably.
Expenditure recognition
All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to the category. Expenditure on raising funds was previously netted off against income but income is now recorded gross.
Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.
Governance costs are those incurred in connection with the administration of the charity and compliance with consitutional and statutory requirements.
Irrecoverable VAT is charged as an expense against the activity for which the expenditure arose.
11
YEAR ENDED 31 MARCH 2023
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) NOTES TO THE FINANCIAL STATEMENTS
1) ACCOUNTING POLICIES (continued)
Taxation
The charity is exempt from taxation in respect of income or capital gains to the extent that such income or gains are applied exclusively to charitable purposes.
Fixed assets
The charity's policy is to capitalise fixed assets over £1,000. Expenditure below this threshold is recognised as expenditure in the year in which it occurs.
Depreciation
Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:
Asset class Depreciation method and rate Equipment 25% straight line
Stocks
No value is placed on stocks of stationery or advertising materials held by the charity.
Debtors and creditors receivable /payable within one year
Debtors and creditors receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in expenditure.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and at bank.
Fund Accounting
Funds held by the charity are either:
Unrestricted general funds - these are funds that can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds - these are funds that can only be used for particular restricted purposes within the objects of the charity.
Designated funds - these are funds that have been set aside by the trustees for particular purposes.
12
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) NOTES TO THE FINANCIAL STATEMENTS (continued) YEAR ENDED 31 MARCH 2023
2) DONATIONS & LEGACIES
| Donations Legacies BSRF fees Gift Aid Other |
Unrestricted funds £ 99,838 373,263 30,000 5,052 5,000 513,153 |
Restricted funds £ - - - - - - |
Total funds 2023 £ 99,838 373,263 30,000 5,052 5,000 513,153 |
Total funds 2022 £ 94,626 11,000 25,620 7,030 3,000 141,276 |
|---|---|---|---|---|
3) OTHER TRADING ACTIVITIES
| Unrestricted funds £ Fundraising activities with BSRF - Website sales 3,881 Other Activities - 3,881 INVESTMENTS Unrestricted funds £ Bank interest receivable 6,808 |
Restricted funds £ - - - - Restricted funds £ - |
Total funds 2023 £ - 3,881 - 3,881 Total funds 2023 £ 6,808 |
Total funds 2022 £ 7,217 3,220 502 10,939 Total funds 2022 £ 52 |
|---|---|---|---|
4) INVESTMENTS
5) INCOME FROM CHARITABLE ACTIVITIES
| Conference income Subscriptions |
Unrestricted funds £ 17,797 15,079 32,876 |
Restricted funds £ - - - |
Total funds 2023 £ 17,797 15,079 32,876 |
Total funds 2022 £ - 15,446 15,446 |
|---|---|---|---|---|
13
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) NOTES TO THE FINANCIAL STATEMENTS (continued) YEAR ENDED 31 MARCH 2023
6) EXPENDITURE ON CHARITABLE ACTIVITIES
| Awards Staff costs Website and magazine costs Support costs (Note 7) Governance costs (Note 8) |
Unrestricted funds £ 3,202 103,643 8,029 50,635 14,344 179,853 |
Restricted funds £ 3,090 - - - - 3,090 |
Total funds 2023 £ 6,292 103,643 8,029 50,635 14,344 182,943 |
Total funds 2022 £ 3,266 116,756 3,376 53,883 8,387 185,668 |
|---|---|---|---|---|
| 7) SUPPORT COSTS Office costs Meetings, travel & subsistence Bank Charges 8) GOVERNANCE COSTS Fees payable to independent examiner Bookkeeping fees Professional fees |
Unrestricted funds £ 45,980 1,675 2,980 50,635 Unrestricted funds £ 3,090 1,606 9,648 14,344 |
Restricted funds £ - - - - Restricted funds £ - - - - |
Total funds 2023 £ 45,980 1,675 2,980 50,635 Total funds 2023 £ 3,090 1,606 9,648 14,344 |
Total funds 2022 £ 52,170 203 1,510 53,883 Total funds 2022 £ 3,240 - 5,147 8,387 |
|---|---|---|---|---|
9) TRANSFER OF ASSETS
The assets of British Scoliosis Research Foundation (BSRF), registered charity no: 803772, were
transferred to SSR with effect from 1 January 2023 following a decision to merge. Four BSRF trustees were appointed to the Board of SSR and BSRF was dissolved. The unrestricted funds transferred have been designated by the Trustees for research purposes.
14
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) NOTES TO THE FINANCIAL STATEMENTS (continued) YEAR ENDED 31 MARCH 2023
10) STAFF COSTS AND EMOLUMENTS
| Salaries and wages Social security costs Employer pension costs |
2023 £ 97,131 5,012 1,500 103,643 |
2022 £ 109,146 5,886 1,724 116,756 |
|---|---|---|
Average number of paid staff on a head count basis for the year was 4 (2022 - 4) None of the employees' emoluments exceeded £60,000
11) TANGIBLE FIXED ASSETS
| COST As at 1 April 2022 Additions At 31 March 2023 DEPRECIATION As at 1 April 2022 Charge for the period At 31 March 2023 NET BOOK VALUE At 31 March 2023 At 31 March 2022 12) DEBTORS Debtors Prepayments 13) CREDITORS: Amounts falling due within one year Creditors Research Grants Payable Accruals |
Equipment £ - 1,776 1,776 - 444 444 1,332 - 2023 £ 5,052 485 5,537 2023 £ 3,167 144,275 4,380 151,822 |
Total £ - 1,776 1,776 - 444 444 1,332 - 2022 £ 6,059 4,340 10,399 2022 £ 2,507 - 4,131 6,638 |
|---|---|---|
15
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) NOTES TO THE FINANCIAL STATEMENTS (continued)
YEAR ENDED 31 MARCH 2023
14) COMMITMENTS UNDER OPERATING LEASES
Total rental payments due under operating leases are as follows:
| Within 1 year Within 2 to 5 years |
2023 £ 10,000 10,000 20,000 |
2022 £ 10,000 20,000 30,000 |
|---|---|---|
15) UNRESTRICTED FUNDS
| General funds Designated funds: a) Ailee Harrison Fund b) Hill, Pedder, Minns Fund c) BSRF funds |
Balance at 1 Apr 2022 £ 298,049 4,825 34,917 - 337,791 |
Income £ 556,778 - - 462,308 1,019,086 |
Expenditure £ (182,837) (150) (3,052) - (186,039) |
Transfers £ - - - - - |
Balance at 31 Mar 2023 £ 671,990 4,675 31,865 462,308 1,170,838 |
|---|---|---|---|---|---|
a) The Ailee Harrison Fund arose from a legacy and is used to provide financial prizes for art projects. b) The Hill, Pedder, Minns Fund arose from 3 legacies and is used to provide grants to members of up to £500 for equipment relating to their condition.
c) Funds transferred from BSRF have been designated for research purposes by the Trustees.
16) RESTRICTED FUNDS
| a) ARISE b) BEIS fund (BSRF) |
Balance at 1 Apr 2022 £ 19,088 - 19,088 |
Income £ - 30,854 30,854 |
Expenditure £ (3,090) - (3,090) |
Transfers £ - - - |
Balance at 31 Mar 2023 £ 15,998 30,854 46,852 |
|---|---|---|---|---|---|
a) ARISE fund provides travel grants of up to £500 to young researchers (the Charles Manning Award).
b) Funds awarded by the BEIS 'Early Career Researchers Fund' to BSRF towards research projects supported by the charity were transferred to SSR following the merger.
16
SCOLIOSIS SUPPORT AND RESEARCH (formerly SCOLIOSIS ASSOCIATION UK) NOTES TO THE FINANCIAL STATEMENTS (continued)
YEAR ENDED 31 MARCH 2023
17) ANALYSIS OF NET ASSETS BETWEEN FUNDS
| Unrestricted funds General Designated funds Restricted funds Total funds |
Fixed assets Net current assets Total £ £ £ 1,332 670,658 671,990 - 498,848 498,848 - 46,852 46,852 1,332 1,216,358 1,217,690 |
|---|---|
18) RELATED PARTY TRANSACTIONS
There were no related party transactions during the year (2022 - nil).
Trustees do not receive any remuneration or fees and no trustees were reimbursed for expenses (2022-nil).
19) UNRESTRICTED FUNDS - PRIOR YEAR
| Balance at 1 Apr 2021 £ General funds 318,539 Designated funds: a) Ailee Harrison Fund 5,000 b) Hill, Pedder, Minns Fund 37,008 360,547 |
Income £ 168,407 - - 168,407 |
Expenditure Transfers Balance at 31 Mar 2022 £ £ £ (194,470) 5,573 298,049 (175) - 4,825 (2,091) - 34,917 (196,736) 5,573 337,791 |
|---|---|---|
- a) The Ailee Harrison Fund arose from a legacy and is used to provide financial prizes for art projects.
b) The Hill, Pedder, Minns Fund arose from 3 legacies and is used to provide grants to members of up to £500 for equipment relating to their condition.
20) RESTRICTED FUNDS - PRIOR YEAR
| a) London Law Trust b) Strongbones Fund c) ARISE |
Balance at 1 Apr 2021 £ 1,315 3,256 21,086 25,657 |
Income £ - - 4 4 |
Expenditure Transfers Balance at 31 Mar 2022 £ £ £ - (1,315) - - (3,256) - (1,000) (1,002) 19,088 (1,000) (5,573) 19,088 |
|---|---|---|---|
a) London Law Trust provided funding for a Baby Project which involved provision of booklets giving advice around pregnancy.
-
b) Strongbones Fund was set up for the provision of family days.
-
c) ARISE fund provides travel grants of up to £500 to young researchers (the Charles Manning Award).
Some expenditure classified as unrestricted in previous years related to the restricted funds above. Transfers to unrestricted funds have been made to correct the closing balances.
17